微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 13.81% | -15.22% | 54.13% | 11/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.96% | -17.11% | 60% | 13/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 5.6% | -15.28% | -67.96% | 5/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 17.48% | -1.52% | 7.31% | 5/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 16.29% | 14.16% | 50.69% | 4/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 10.81% | 21.05% | 63.54% | 3/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 6.61% | 28.35% | -62.76% | 3/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 17.75% | 35.29% | 24.39% | 11/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 14.27% | 18.33% | 59.8% | 14/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 8.93% | 11.9% | 73.4% | 18/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.15% | -0.58% | -60.75% | 14/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 13.12% | -13.74% | 8.79% | 30/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 12.06% | -8.36% | 51.13% | 22/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 7.98% | -3.27% | 54.05% | 27/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.18% | 16.67% | -65.94% | 11/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 15.21% | 4.68% | 15.58% | 32/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 13.16% | 5.7% | 59.52% | 23/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.25% | 13.95% | 85.81% | 30/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.44% | 14.73% | -69.44% | 18/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 14.53% | 11.77% | 16.71% | 33/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 12.45% | 14.22% | 71.96% | 20/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 7.24% | 11.04% | 87.08% | 29/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.87% | 9.94% | -70.23% | 20/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 13% | 34.3% | 19.27% | 37/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 10.9% | 33.25% | 67.18% | 21/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 6.52% | 32.25% | 85.23% | 28/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.52% | 23.51% | -63.64% | 20/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9.68% | -14.18% | 18.34% | 52/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.18% | -13.99% | 65.92% | 43/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.93% | -24.27% | 72.98% | 44/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.85% | -16.42% | -74.73% | 31/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.28% | -18.38% | 18.61% | 47/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.51% | -10.11% | 46.08% | 26/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 6.51% | -31.97% | 90.91% | 29/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.41% | 2% | -75.33% | 22/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 13.82% | -25.82% | 30.62% | 37/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 10.58% | 2% | 10.55% | 24/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 9.57% | 2% | -48.63% | 14/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |